Plum J, De Smedt M, Leclercq G
Department of Bacteriology, Virology and Immunology, University Hospital Gent, Belgium.
J Immunol. 1993 Apr 1;150(7):2706-16.
Addition of human rIL-7 to fetal thymic organ culture started at day 13, 14, or 15 did not influence the number of cells generated during a 12-day culture period. However, the IL-7 treatment resulted in a preferential expansion of cells with a phenotype characteristic for cells at an early step of differentiation. The cells were CD4-CD8-CD3-CD2- and SCA-1+. Analysis of the coordinate expression of CD44 and CD25 on these cells showed that the majority of the cells were either CD44+CD25- or CD44+CD25intermediate. TCR-alpha beta cells were present but in a significantly lower number as compared to the control cultures. The cell number of TCR-gamma delta cells was increased. All these effects were moderate after 6 days, but unequivocal after 12 days of culture. Treatment of the fetal organ culture with mAb-neutralizing murine IL-7 resulted in an inhibition of the proliferation of the fetal thymocytes. No particular subset studied was preferentially inhibited. By using a model of reconstitution of 14-day embryonic thymuses depleted of thymocytes by deoxyguanosine and reconstituted with fetal day 13 liver cells and set up in organ culture with or without IL-7, it was shown in a clear cut way that IL-7 indeed promotes expansion of the early precursor cells and TCR-gamma delta cells, but prevents the generation of TCR-alpha beta cells. In addition, reconstitution experiments were set up in the presence of mAb-neutralizing murine IL-7. This treatment resulted in the inhibition of the growth of the fetal thymocytes without inhibiting preferentially a particular subset. These data indicate that IL-7 acts at an early step of T cell differentiation and plays a role to expand precursor cells, but prevents this population from additional differentiation towards the TCR-alpha beta pathways, whereas the differentiation towards TCR-gamma delta cells is not influenced or even enhanced.
在第13、14或15天开始向胎胸腺器官培养物中添加人重组白细胞介素-7(rIL-7),在12天的培养期内不会影响所产生的细胞数量。然而,白细胞介素-7处理导致具有分化早期细胞表型特征的细胞优先扩增。这些细胞为CD4-CD8-CD3-CD2-且SCA-1+。对这些细胞上CD44和CD25的协同表达分析表明,大多数细胞为CD44+CD25-或CD44+CD25中间型。TCR-αβ细胞存在,但与对照培养物相比数量显著减少。TCR-γδ细胞的数量增加。所有这些效应在培养6天后较为适度,但在培养12天后则明确无疑。用单克隆抗体中和小鼠白细胞介素-7处理胎器官培养物,导致胎胸腺细胞增殖受到抑制。所研究的特定亚群均未受到优先抑制。通过使用一个模型,即对用脱氧鸟苷耗尽胸腺细胞的14天胚胎胸腺进行重建,并用第13天胎肝细胞进行重建,并在有或无白细胞介素-7的情况下建立器官培养,明确表明白细胞介素-7确实促进早期前体细胞和TCR-γδ细胞的扩增,但阻止TCR-αβ细胞的产生。此外,在存在单克隆抗体中和小鼠白细胞介素-7的情况下进行重建实验。这种处理导致胎胸腺细胞生长受到抑制,但没有优先抑制特定亚群。这些数据表明,白细胞介素-7在T细胞分化的早期阶段起作用,在扩增前体细胞方面发挥作用,但阻止该群体进一步向TCR-αβ途径分化,而向TCR-γδ细胞的分化则不受影响甚至增强。